نتایج جستجو برای: cyp2c19

تعداد نتایج: 2034  

Journal: :Genetics and molecular research : GMR 2016
Y M Guo Z C Zhao L Zhang H Z Li Z Li H L Sun

The goal of this study was to explore the polymorphisms of CYP2C19 (CYP2C19*2, CYP2C19*3) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) on clopidogrel therapy in Zhengzhou city for guidance on clinical medication and reduction in the incidence of thromboembolic events. Two hundred and thirty-four ACS patients undergoing PCI were included in t...

2013
Xiang Xie Yi-Tong Ma Yi-Ning Yang Xiao-Mei Li Xiang Ma Zhen-Yan Fu Ying-Ying Zheng Bang-Dang Chen Fen Liu

BACKGROUND Several studies have indicated that CYP2C19 loss-of-function polymorphisms have a higher risk of stent thrombosis (ST) after percutaneous coronary interventions (PCIs). However, this association has not been investigated thoroughly in a Chinese population. In this study, we aimed to determine the effect of CYP2C19*2 and CYP2C19*3 loss-of-function polymorphisms on the occurrence of ST...

2015
Jessica A. Roseberry Baker Stephen D. Hall Yingying Guo

It is important to examine the cytochrome P450 2C19 (CYP2C19) genetic contribution to drug disposition and responses of CYP2C19 substrates during drug development. Design of such clinical trials requires projection of genotype-dependent in vivo clearance and associated variabilities of the investigational drug, which is not generally available during early stages of drug development, but is ess...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2004
Carole Giraud Agnès Tran Elisabeth Rey Jean Vincent Jean-Marc Tréluyer Gérard Pons

The specific cytochrome P450 (P450) isoforms mediating the biotransformations of clobazam (CLB) and those of its major metabolites, N-desmethylclobazam (NCLB) and 4'-hydroxyclobazam were identified using cDNA-expressed P450 and P450-specific chemical inhibitors. Among the 13 cDNA-expressed P450 isoforms tested, CLB was mainly demethylated by CYP3A4, CYP2C19, and CYP2B6 and 4'-hydroxylated by CY...

2014
Andy Z. X. Zhu Qian Zhou Lisa Sanderson Cox Jasjit S. Ahluwalia Neal L. Benowitz Rachel F. Tyndale

Bupropion is used clinically to treat depression and to promote smoking cessation. It is metabolized by CYP2B6 to its activemetabolite hydroxybupropion, yet alterations in CYP2B6 activity have little impact on bupropion plasma levels. Furthermore, less than 10%of a bupropion dose is excreted as urinary bupropion and its characterized metabolites hydroxybupropion, threohydrobupropion, and erythr...

Journal: :مجله دانشگاه علوم پزشکی مازندران 0
حمید بدلی hamid badali associate professor, invasive fungi research centre, department of medical mycology and parasitology, faculty of medicine, mazandaran university of medical sciences, sari, iranدانشیار، مرکز تحقیقات قارچ های تهاجمی، گروه انگل شناسی و قارچ شناسی پزشکی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران افسانه واعظی afsane vaezi phd student in medical mycology, student research committee, faculty of medicine, mazandaran university of medical sciences, sari, iranدانشجوی دکتری قارچ شناسی پزشکی، کمیته تحقیقات دانشجویی دانشگاه علوم پزشکی مازندران، ساری، ایران نرگس اصلانی narges aslani phd student in medical mycology, student research committee, faculty of medicine, mazandaran university of medical sciences, sari, iranدانشجوی دکتری قارچ شناسی پزشکی، کمیته تحقیقات دانشجویی دانشگاه علوم پزشکی مازندران، ساری، ایران نینا زاهدی nina zahedi msc in medical mycology, invasive fungi research centre, faculty of medicine, mazandaran university of medical sciences, sari, iranکارشناسی ارشد قارچ شناسی پزشکی، مرکز تحقیقات قارچ های تهاجمی، دانشکده پزشکی، دانشگاه علوم پزشکی مازندران، ساری، ایران محمدرضا شیران mohammad reza shiran associate professor, immunogenetic research center, faculty of medicine, mazandaran university of medical sciences, sari, iranساری: دانشگاه علوم پزشکی مازندران، دانشکده پزشکی

voriconazole is an antifungal triazole, approved for management of invasive fungal diseases in patients. it is absorbed during two hours and its serum levels will be above 90%, based on the underlying factors, when the drug is administered orally. voriconazole shows a propotional increase in an area under the plasma concentration-time curve (auc), with increasing dose. plasma protein binding of...

2013
Leena H Saeed Ahmed Y Mayet

UNLABELLED CYP2C19 is a cytochrome P450 enzyme, which is involved in the metabolism of some clinically important medications and is encoded by a highly polymorphic gene. There is no available data on the distribution of the CYP2C19 *4 and *17 mutant alleles in the Saudi Arabian population. The aim of the study was to determine different CYP2C19 mutant allele (*2, *4 and *17) frequencies in heal...

Journal: :Drug metabolism and pharmacokinetics 2009
Chakradhara Rao Uppugunduri Satyanarayana Anichavezhi Devendran Muthukumaran Jayaraman Jayakanthan Mannu Premendu P Mathur Shewade Deepak Gopal Krishnamoorthy Rajagopal Adithan Chandrasekaran

CYP2C19 is a polymorphic enzyme which metabolizes several clinically important drugs including proguanil. Variation in the 5' regulatory region may influence CYP2C19 activity. This study evaluates the relationship between proguanil metabolic ratio and genetic variations of CYP2C19 in a South Indian population. Fifty unrelated healthy subjects were genotyped for CYP2C19 (*)2 and (*)3 alleles and...

2014
Chao-Hung Kuo Chien-Yu Lu Hsiang-Yao Shih Chung- Jung Liu Meng-Chieh Wu Huang-Ming Hu Wen-Hung Hsu Fang-Jung Yu Deng-Chyang Wu

The known factors that have contributed to the decline of Helicobacter pylori (H. pylori ) eradication rate include antibiotic resistance, poor compliance, high gastric acidity, high bacterial load, and cytochrome P450 2C19 (CYP2C19) polymorphism. Proton pump inhibitor (PPI) is important in the eradication regimen. The principal enzyme implicated in the metabolism of PPIs is CYP2C19. The effect...

Journal: :Drug discoveries & therapeutics 2010
S Kimura S Hasegawa A Kobayashi H Yamaguchi M Yohda T Kubota

Gene polymorphism is considered to be one of the causes of poor metabolism (PM), and approximately 20 mutants have been reported for CYP2C19 thus far. In our analysis of the CYP2C19*3 mutant gene, we detected new CYP2C19 SNPs by cross checking with different procedures. We confirmed a new c>a mutation at the 629 position. Among the 587 healthy Japanese volunteers studied, two subjects carrying ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید